Ariel Galapo Kann

4PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples health policyPacific Peoples medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 22, 2025
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.

Thomas Powles, Ariel G Kann, Daniel Castellano

|Sep 16, 2024
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

Thomas Powles, James W F Catto, Matthew D Galsky

|Apr 15, 2021
Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries.

Felipe Moraes Toledo Pereira, Adriano Gonçalves E Silva, Aldo Lourenço Abbade Dettino

|Apr 15, 2021
Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).

Fernando Cotait Maluf, Felipe Moraes Toledo Pereira, Adriano Gonçalves Silva

Pageof 1

Frequent Collaborators

2 joint publications

Felipe Moraes Toledo Pereira

2 joint publications

Adriano Gonçalves Silva

2 joint publications

Aldo Lourenço Abbade Dettino

2 joint publications

Andrey Soares